Savara (SVRA) Shares Outstanding (Diluted Average) (2021 - 2026)

Savara (SVRA) reported Shares Outstanding (Diluted Average) of $253.3 million for Q1 2026, up 17.18% year-over-year from $216.1 million in Q1 2025, and up 13.89% quarter-over-quarter from $222.4 million in Q4 2025.

Savara (SVRA) Shares Outstanding (Diluted Average) (2021 - 2026) Analysis & Trends

Savara (SVRA) has 6 years of Shares Outstanding (Diluted Average) data on file, last reported at $253.3 million in Q1 2026.

  • Shares Outstanding (Diluted Average) for Q1 2026 came in at $253.3 million, up 17.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $253.3 million (up 17.18% YoY), and the FY2025 annual result was $222.4 million, up 12.21% from the prior year.
  • Shares Outstanding (Diluted Average) advanced to $253.3 million in Q1 2026 per SVRA's latest filing, from $222.4 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $253.3 million in Q1 2026 and troughed at $152.8 million in Q1 2022.
  • A 5-year average of $184.5 million and a median of $182.6 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
  • The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Diluted Average) climbed 0.01% in 2023, then climbed 19.97% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $152.8 million in 2022, then climbed by 8.14% to $165.2 million in 2023, then rose by 19.97% to $198.2 million in 2024, then rose by 12.21% to $222.4 million in 2025, then climbed by 13.89% to $253.3 million in 2026.
  • Business Quant data shows SVRA's Shares Outstanding (Diluted Average) at $253.3 million in Q1 2026, $222.4 million in Q4 2025, and $216.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 Savara 1.39 Bn 1.39 Bn - 253.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 253.28 Mn
Dec 31, 2025 222.39 Mn
Sep 30, 2025 216.46 Mn
Jun 30, 2025 216.29 Mn
Mar 31, 2025 216.15 Mn
Dec 31, 2024 198.19 Mn
Sep 30, 2024 192.40 Mn
Jun 30, 2024 182.57 Mn
Mar 31, 2024 182.55 Mn
Dec 31, 2023 165.20 Mn
Sep 30, 2023 174.70 Mn
Jun 30, 2023 152.80 Mn
Mar 31, 2023 152.78 Mn
Dec 31, 2022 152.77 Mn
Sep 30, 2022 152.77 Mn
Jun 30, 2022 152.77 Mn
Mar 31, 2022 152.77 Mn
Dec 31, 2021 133.92 Mn
Sep 30, 2021 127.62 Mn
Jun 30, 2021 152.46 Mn